A Double-Blind, Placebo-Controlled, Randomized, Single and Multiple Ascending Dose Study (Including Food Effect, pH Effect, and Japanese Bridging Study) of the Safety, Pharmacokinetics, and Exploratory Pharmacodynamics of Oral BMS-986278 Administration in Healthy Participants
Active, no longer recruiting
Phase of Trial: Phase I
Latest Information Update: 27 Dec 2018
At a glance
- Drugs BMS-986278 (Primary)
- Indications Unspecified
- Focus Adverse reactions
- Sponsors Bristol-Myers Squibb
- 17 Dec 2018 Planned End Date changed from 3 Dec 2018 to 5 Mar 2019.
- 17 Dec 2018 Planned primary completion date changed from 2 Dec 2018 to 3 Mar 2019.
- 03 Dec 2018 Status changed from recruiting to active, no longer recruiting.